lobbying_activities: 2802780

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2802780	07e68d40-7268-4070-8444-5f18d118a81d	Q1	AMERICAN HEART ASSOCIATION	2525	AMERICAN HEART ASSOCIATION	2022	first_quarter	TOB	Consolidated Appropriations Act, 2022 (Pub.L. 117-103), sections pertaining to FDA authority to regulate synthetic nicotine FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		200000	0	0	2022-04-20T17:12:18-04:00